Not applicableStudy completedNCT02608112What this trial is testingStudy to Describe Real World Drug Retention Rate of the Tocilizumab at One YearWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 291
Large-scale testing (Phase 3)Study completedNCT01587989What this trial is testingRoActemra/Actemra (Tocilizumab) With or Without Methotrexate in Patients With Mild to Moderate Rheumatoid Arthritis With an Inadequate Response to MethotrexateWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 77
Large-scale testing (Phase 3)Study completedNCT01995201What this trial is testingSubcutaneous RoActemra/Actemra (Tocilizumab) as Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Patients With Active Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 401
Early research (Phase 1)Study completedNCT02404558What this trial is testingSingle-dose Study to Describe the Safety of Sarilumab and Tocilizumab in Patients With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Sanofi 30
Post-approval studies (Phase 4)Study completedNCT01399697What this trial is testingRoActemra/Actemra (Tocilizumab) in Combination With Methotrexate Versus RoActemra/Actemra Monotherapy in Patients With Rheumatoid Arthritis and an Inadequate Response to MethotrexateWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 261
Large-scale testing (Phase 3)Study completedNCT01034137What this trial is testingTocilizumab and Methotrexate in Combination or as Monotherapy in Treatment-Naïve Patients With Early Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 317
Large-scale testing (Phase 3)Study completedNCT00109408What this trial is testingAssess the Safety and Efficacy of Tocilizumab in Patients With Active Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 673
Large-scale testing (Phase 3)Study completedNCT01987479What this trial is testingA Study on Safety and Efficacy of Tocilizumab (RoActemra/Actemra) Alone or in Combination With Non-Biologic Antirheumatics in Participants With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 150
Testing effectiveness (Phase 2)Study completedNCT03062579What this trial is testingA Longitudinal Study of ACTEMRA® (Tocilizumab) as Monotherapy in Highly Active NMOSDWho this might be right forNeuromyelitis Optica Spectrum DisordersNeuromyelitis OpticaDevic's Disease Fu-Dong Shi 10
Not applicableEnded earlyNCT01643863What this trial is testingA Non-Interventional Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid Arthritis (MONACO)Who this might be right forRheumatoid Arthritis Hoffmann-La Roche 1
Not applicableStudy completedNCT01705730What this trial is testingA Non-Interventional Study of Rheumatoid Arthritis Patients Treated With RoActemra/Actemra (Tocilizumab) in MonotherapyWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 71
Post-approval studies (Phase 4)Study completedNCT01119859What this trial is testingTocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 326
Large-scale testing (Phase 3)Study completedNCT03155347What this trial is testingAn Efficacy and Safety Study of Subcutaneous Tocilizumab in Combination With Methotrexate (MTX) and as Monotherapy Versus MTX in Participants With Moderate to Severe Rheumatoid Arthritis With Inadequate Response to Current Disease-Modifying Antirheumatic Drug (DMARD) TherapyWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 340
Not applicableStudy completedNCT02648035What this trial is testingEMBRACE-SC: Observational Study of Subcutaneous (SC) Tocilizumab Alone or in Combination With Conventional Disease-Modifying Antirheumatic Drugs (cDMARDs) in Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 200
Large-scale testing (Phase 3)Study completedNCT01941095What this trial is testingSubcutaneous Tocilizumab as Monotherapy and/or in Combination With Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs) in Participants With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 100
Not applicableStudy completedNCT05133895What this trial is testingPilot Study of Tocilizumab Monotherapy for Active Chronic PeriaortitisWho this might be right forChronic PeriaortitisTocilizumab Monotherapy Peking Union Medical College Hospital 12
Post-approval studies (Phase 4)Study completedNCT04157010What this trial is testingTocilizumab REMission in Early RAWho this might be right forRheumatoid Arthritis University of Leeds 20
Post-approval studies (Phase 4)Study completedNCT01010503What this trial is testingTocilizumab With or Without Methotrexate in Patients With Rheumatoid Arthritis.Who this might be right forRheumatoid Arthritis Hoffmann-La Roche 32
Large-scale testing (Phase 3)Study completedNCT01254331What this trial is testingAn Open-label Study With Tocilizumab in Patients With Rheumatoid Arthritis in a Local EnvironmentWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 51
Not applicableStudy completedNCT01669902What this trial is testingAn Observational Study of RoActemra/Actemra (Tocilizumab) in Monotherapy in Patients With Rheumatoid ArthritisWho this might be right forRheumatoid Arthritis Hoffmann-La Roche 107